Company / CapEx per Share
Dare Bioscience, Inc. CapEx per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.07
FY2025
5-year range
$0.00 / $0.08
FY2021-FY2025
Trend
-12.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2022 to $0.23 in FY2014.
Based on SEC 10-K filings.
0.07 in FY2025 with a 10-year CAGR of +68.9%.
Improved from $0.00 to $0.07 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +624.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- +68.9%
Key checks
Key Insights
- In FY2025, capex per share decreased 12.8% year-over-year.
- Peak capex per share was recorded in FY2014.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -12.8% |
| FY2024 | $0.08 | +10061.4% |
| FY2023 | $0.00 | +329.7% |
| FY2022 | $0.00 | -97.9% |
| FY2016 | $0.01 | +2265.5% |
| FY2015 | $0.00 | -99.8% |
| FY2014 | $0.23 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026